Scientists up the ante in war against "superbugs"August 30, 2001Scientists have discovered a weakness in tuberculosis-causing "superbugs" which could help doctors fight the emergence of multi-drug resistant tuberculosis, says Dr Jim Naismith speaking at the BA Festival of Science at the University of Glasgow today [3rd Spetember 2001]. Tuberculosis (TB) affects more than 50 million people worldwide. Just like normal TB, multi-drug resistant TB is a disease of the respiratory system - but is resistant to many of the medicines that doctors use to treat the disease. In the UK, multi-drug resistant TB is becoming a significant problem, especially in Intensive Care Units where the most vulnerable are treated. Dr Naismith and colleagues have worked out how bacteria that cause this type of tuberculosis produce two of the essential sugars they need to survive. By targeting new antibiotics that cut off some of the sugar producing enzymes in the bacteria, they hope to be able to counter the growing threat of these superbugs. "Bacterial infection has re-emerged as a serious health problem around the world, particularly because of the rise in pathogens that are resistant to conventional antibiotics," says Dr Naismith. "In the UK, multi-drug resistant tuberculosis, which is very hard to treat with current medicines, is emerging as a major health problem. In many developing countries, drug tolerant bacteria are endemic." The science carried out by the research team involves determining the full three-dimensional structure of enzyme molecules that make sugars in the bacterial cell. This requires a great deal of painstaking experimental work but at the end produces a three dimensional model of the protein - magnifying the protein structure 100 million times. This allows the researchers to see exactly how the protein works and, more importantly, to see how they can stop it from working.
| |||||||||||||||||||||
|
Related Tuberculosis News Articles New Electrostatic-based DNA Microarray Technique Could Revolutionize Medical Diagnostics The dream of personalized medicine - in which diagnostics, risk predictions and treatment decisions are based on a patient's genetic profile - may be on the verge of being expanded beyond the wealthiest of nations with state-of-the-art clinics. Predicting TB outbreaks based on the first 2 cases Outbreaks of tuberculosis (TB) may be able to be identified by looking at certain characteristics of the first two patients, according to new research. Radical reform is needed to stop the 'inhumane' practice of transplant tourism The UK government must bring in presumed consent to organ donation or allow a controlled donor compensation programme for unrelated live donors, in order to bring the "inhumane" practice of transplant tourism from the UK to an end, claims a doctor in this week's BMJ. Pitt-led Researchers Find Source of Drug-Tolerant Tuberculosis Possibly Behind TB Relapses, Intensity of Treatment University of Pittsburgh-led researchers discovered that the primary bacteria behind tuberculosis can grow on surfaces and that drug-tolerant strains flourish in these bacterial communities, the research team recently reported in "Molecular Microbiology." US soldiers in high-tuberculosis areas face new epidemic: false positives U.S. Army service members are increasingly deployed in regions of the world where tuberculosis (TB) is rampant, such as Iraq and Afghanistan, and the military now faces a growing medical problem. Tuberculosis not the only risk from new immunological drugs A new survey cautions physicians that drugs commonly prescribed for patients suffering from immunological disorders such as rheumatoid arthritis and inflammatory bowel disease may carry risks of serious infections other than the known risk of tuberculosis. Pilot study reinforces use of portable anteroom HEPA filtration Amidst an increase in new tuberculosis cases, researchers have begun investigating the effectiveness of new operating room filtration systems designed to protect staff and patients. X-rays power discoveries at Chicago's Field Museum Digital medical imaging and information technology from Carestream Health, Inc., is playing a key role in helping The Field Museum of Chicago discover and analyze secrets hidden within its world-class collections. Study shows common vitamin and other micronutrient supplements reduce risks of TB recurrence New findings show a link between micronutrient supplementation and reduced risk of recurrence during tuberculosis chemotherapy, according to a study published in the June 1 issue of The Journal of Infectious Diseases, now available online. NIAID describes research priorities to fight drug-resistant tuberculosis Tuberculosis (TB) has long been one of the world's great killers. Now, forms of drug-resistant TB--multidrug (MDR) and extensively drug-resistant (XDR)--are occurring at an ominous and accelerating rate. More Tuberculosis News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||